Protagenic Therapeutics (PTIX) — Financial Flexibility Index
Protagenic Therapeutics (PTIX) has a Financial Flexibility Index of -0.06x as of December 2025. Free cash flow of $-410.42K (operating CF $-410.42K minus capex $6.00) represents 0% of total liabilities ($6.82 Million). Also explore PTIX net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Protagenic Therapeutics Financial Flexibility Index (1995–2025)
Historical Financial Flexibility Index trend for Protagenic Therapeutics across 31 annual periods. Check Protagenic Therapeutics (PTIX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Protagenic Therapeutics (1995–2025)
Year-by-year free cash flow to debt coverage for Protagenic Therapeutics. For the full company profile including market capitalisation, see Protagenic Therapeutics (PTIX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.61x | $-4.14 Million | $-4.14 Million | $6.82 Million | ▲ +86.4% |
| 2024 | -4.47x | $-4.22 Million | $-4.22 Million | $942.76K | ▲ +17.5% |
| 2023 | -5.42x | $-3.55 Million | $-3.70 Million | $655.25K | ▼ -204.9% |
| 2022 | -1.78x | $-1.99 Million | $-1.99 Million | $1.12 Million | ▲ +28.9% |
| 2021 | -2.50x | $-2.80 Million | $-2.80 Million | $1.12 Million | ▼ -276.6% |
| 2020 | -0.66x | $-1.35 Million | $-1.35 Million | $2.03 Million | ▼ -101.2% |
| 2019 | -0.33x | $-487.99K | $-487.99K | $1.48 Million | ▲ +72.0% |
| 2018 | -1.18x | $-1.07 Million | $-1.07 Million | $907.77K | ▲ +52.0% |
| 2017 | -2.46x | $-1.38 Million | $-1.38 Million | $561.69K | ▼ -47.6% |
| 2016 | -1.67x | $-1.14 Million | $-1.14 Million | $684.86K | ▼ -210.9% |
| 2015 | -0.54x | $-377.00K | $-378.00K | $704.00K | ▲ +10.5% |
| 2015 | -0.60x | $-377.00K | $-378.00K | $630.00K | ▲ +76.0% |
| 2014 | -2.50x | $-789.00K | $-790.00K | $316.00K | ▲ +0.0% |
| 2013 | -2.50x | $-789.00K | $-790.00K | $316.00K | ▼ -13910.0% |
| 2012 | -0.02x | $-324.00K | $-324.00K | $18.18 Million | ▲ +98.2% |
| 2010 | -1.00x | $-11.21 Million | $-11.25 Million | $11.17 Million | ▼ -728.0% |
| 2009 | -0.12x | $-2.33 Million | $-3.02 Million | $19.25 Million | ▼ -145.8% |
| 2008 | 0.26x | $6.38 Million | $4.36 Million | $24.11 Million | ▲ +138.0% |
| 2007 | -0.70x | $-4.94 Million | $-5.21 Million | $7.10 Million | ▼ -395.1% |
| 2006 | 0.24x | $1.01 Million | $931.00K | $4.27 Million | ▲ +150.7% |
| 2005 | -0.47x | $-44.00K | $-44.00K | $94.47K | ▼ -133.2% |
| 2004 | -0.20x | $-842.00K | $-842.00K | $4.21 Million | ▼ -152.2% |
| 2003 | 0.38x | $3.35 Million | $1.87 Million | $8.76 Million | ▼ -19.8% |
| 2002 | 0.48x | $4.13 Million | $2.35 Million | $8.65 Million | ▼ -12.5% |
| 2001 | 0.55x | $5.29 Million | $1.50 Million | $9.71 Million | ▼ -26.7% |
| 2000 | 0.74x | $6.74 Million | $3.51 Million | $9.06 Million | ▲ +1643.2% |
| 1999 | 0.04x | $412.00K | $331.00K | $9.66 Million | ▲ +187.0% |
| 1998 | -0.05x | $-369.00K | $-434.00K | $7.53 Million | ▼ -118.4% |
| 1997 | 0.27x | $657.00K | $-2.20 Million | $2.47 Million | ▲ +23.6% |
| 1996 | 0.22x | $1.19 Million | $-230.00K | $5.53 Million | ▲ +5.2% |
| 1995 | 0.20x | $730.00K | $-600.00K | $3.57 Million | — |